U.S., Nov. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07925983) titled 'A Study to Assess How Intravenous and Subcutaneous Administrations of Trosunilimab Move Through the Body of Healthy Adult Participants' on Oct. 21.
Brief Summary: The objective of this study is to assess the pharmacokinetic (PK), immunogenicity and safety following trosunilimab SC and trosunilimab IV doses in healthy adult participants.
Study Start Date: Oct. 13
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteer
Intervention:
DRUG: Trosunilimab
Subcutaneous (SC) Injection
DRUG: Trosunilimab
Intravenous (IV) Injection
Recruitment Status: RECRUITING
Sponsor: AbbVie
Published by HT Digital Content Services with permiss...